If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
249.50    0.50 (0.20%)
Bid:
245.50
Ask:
251.50
Spread: 6.00 (2.444%)
Market Cap: £145.55m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Rule 8.1- Gleeson(M J)Grp PLC

30 Mar 2006 12:03

Gleeson(M J)Group PLC30 March 2006 FORM 8.1b 30 March 2006 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Dermot GleesonCompany dealt in Gleeson (MJ) plcClass of relevant security to which the Ordinary Sharesdealings being disclosed relate (Note 2) Date of dealing 27 March 2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number Number (%) (%) (1) Relevant securities 720,759 (1.4%) (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 720,759 (1.4%) (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number Number (%) (%) (1) Relevant securities n/a (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details Ordinary Shares Options 2,129 Options Held No Held Exercisable Employee options Price From ToSharesave 2003 1.48 1,550 1 September 2005 31 March 2006Sharesave 2004 1.89 579 1 September 2005 31 March 2006 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 443 £3.745 (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5) e.g. CFDn/a (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, e.g. Expiry Option money selling, securities to American,e.g. call option purchasing, which the option price European etc. date paid/received varying etc. relates (Note 7) per unit (Note 5)n/a (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5)n/a (d) Other dealings (including new securities) (Note 4) n/a 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated.n/a Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 30 March 2006 Contact name Edwin Lawrie Telephone number 020 8644 4321 Name of offeree/offeror with which associated Gleeson (MJ) plcSpecify category and nature of associate status (Note 10) Director Notes The Notes on Form 8.1 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.